Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 15, 2018Molecular CancerOpen Access

The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMichaela PoliakováUniversity Hospital of BernDADaniel M. AebersoldUniversity of BernYZYitzhak ZimmerUniversity of Bern

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Poliaková et al. (2018) studied this question.

synapsesocial.com/papers/6a70602af44fa9f079de007fhttps://doi.org/10.1186/s12943-018-0798-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells2001 · 77 citations
  2. 2The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC‐derived cardiomyocytes2017 · 57 citations
  3. 3Host-Microbe Co-metabolism Dictates Cancer Drug Efficacy in C. elegans2017 · 266 citations
  4. 4Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy2015 · 31 citations